Global Gene Profiling of VCP-associated Inclusion Body Myopathy

Clinical and Translational Science

Volumn 5, Issue 3, 2012, Pages 226-234

  Nalbandian, Angèle ^a   Ghimbovschi, Svetlana ^b   Radom Aizik, Shlomit ^a   Dec, Eric ^a   Vesa, Jouni ^a   Martin, Barbara ^c   Knoblach, Susan ^b   Smith, Charles ^c   Hoffman, Eric ^b   Kimonis, Virginia E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^c UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Actin cytoskeleton; Autophagy; FoxO transcription factor; Global microarray; Growth factors; Inclusion body myopathy with Paget's disease of bone and frontotemporal dementia (IBMPFD); Lysosome; Muscle biopsies; R155H mutation; Signaling intermediates and cascades; Valosin containing protein (VCP)

Indexed keywords

VALOSIN CONTAINING PROTEIN;

ACTIN FILAMENT; ADULT; ARTICLE; AUTOPHAGY; AUTOSOMAL DOMINANT DISORDER; CLINICAL ARTICLE; DNA FINGERPRINTING; DNA MICROARRAY; FEMALE; FRONTOTEMPORAL DEMENTIA; GENE EXPRESSION; GENETIC ANALYSIS; HUMAN; HUMAN TISSUE; INCLUSION BODY MYOPATHY WITH PAGET BONE DISEASE AND FRONTOTEMPORAL DEMENTIA; MALE; MOLECULAR MECHANICS; MYOPATHY; PAGET BONE DISEASE; PRIORITY JOURNAL; SKELETAL MUSCLE; VASTUS LATERALIS MUSCLE;

ADENOSINE TRIPHOSPHATASES; ADULT; CASE-CONTROL STUDIES; CELL CYCLE PROTEINS; FEMALE; GENE EXPRESSION PROFILING; GENE REGULATORY NETWORKS; HUMANS; MALE; MIDDLE AGED; MYOSITIS, INCLUSION BODY; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

EID: 84862200613     PISSN: 17528054     EISSN: 17528062     Source Type: Journal    
DOI: 10.1111/j.1752-8062.2012.00407.x     Document Type: Article

References (49)

1. Watts GD, Thomasova D, Ramdeen SK, Fulchiero EC, Mehta SG, Drachman DA, Weihl CC, Jamrozik Z, Kwiecinski H, Kaminska A, et al. Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein. Nat. Genet. 2004;36:377-381.
2. Kimonis VE, Kovach MJ, Waggoner B, Leal S, Salam A, Rimer L, Davis K, Khardori R, Gelber D. Clinical and molecular studies in a unique family with autosomal dominant limb-girdle muscular dystrophy and Paget disease of bone. Genet. Med. 2000;2:232-241.
3. Nalbandian A, Donkervoort S, Dec E, Badadani M, Katheria V, Rana P, Nguyen C, Mukherjee J, Caiozzo V, Martin B, et al. The multiple faces of Valosin-containing protein-associated diseases: inclusion body myopathy with Paget's disease of bone, frontotemporal dementia, and amyotrophic lateral sclerosis. J. Mol. Neurosci. 2011.
4. Weihl CC, Temiz P, Miller SE, Watts G, Smith C, Forman M, Hanson PI, Kimonis V, Pestronk A. TDP-43 accumulation in inclusion body myopathy muscle suggests a common pathogenic mechanism with frontotemporal dementia. J. Neurol., Neurosurg., Psychiatry. 2008;79:1186-1189.
5. Kimonis VE, Mehta SG, Fulchiero EC, Thomasova D, Pasquali M, Boycott K, Neilan EG, Kartashov A, Forman MS, Tucker S, et al. Clinical studies in familial VCP myopathy associated with Paget disease of bone and frontotemporal dementia. Am. J. Med. Genet. A 2008;146:745-757.
6. Kimonis VE, Watts GD. Autosomal dominant inclusion body myopathy, Paget disease of bone, and frontotemporal dementia. Alzheimer Dis. Assoc. Disord. 2005;19(Suppl 1):S44-47.
7. McBride TI. Paget's disease and muscular dystrophy. Report of an unusual association in one family. Scottish Med. J. 1966;11:238-243.
8. Farpour F, Tehranzadeh J, Donkervoort S, Smith C, Martin B, Vanjara P, Osann K, Kimonis VE. Radiological features of Paget disease of bone associated with VCP myopathy. Skeletal Radiol. 2011.
9. Rosso SM, Kamphorst W, de Graaf B, Willemsen R, Ravid R, Niermeijer MF, Spillantini MG, Heutink P, van Swieten JC.Familial frontotemporal dementia with ubiquitin-positive inclusions is linked to chromosome 17q21-22. Brain. 2001;124:1948-1957.
10. Foster NL, Wilhelmsen K, Sima AA, Jones MZ, D'Amato CJ, Gilman S. Frontotemporal dementia and parkinsonism linked to chromosome 17: a consensus conference. Conference Participants. Ann. Neurol. 1997;41:706-715.
11. Kovach MJ, Waggoner B, Leal SM, Gelber D, Khardori R, Levenstien MA, Shanks CA, Gregg G, Al -Lozi MT, Miller T, et al. Clinical delineation and localization to chromosome 9p13.3-p12 of a unique dominant disorder in four families: hereditary inclusion body myopathy, Paget disease of bone, and frontotemporal dementia. Mol. Genet. Metab. 2001;74:458-475.
12. Kakizuka A. Roles of VCP in human neurodegenerative disorders. Biochem. Soc. Trans. 2008;36:105-108.
13. Vesa J, Su H, Watts GD, Krause S, Walter MC, Martin B, Smith C, Wallace DC, Kimonis VE. Valosin containing protein associated inclusion body myopathy: abnormal vacuolization, autophagy and cell fusion in myoblasts. Neuromuscul. Disord. 2009;19:766-772.
14. Fernandez-Saiz V, Buchberger A. Imbalances in p97 co-factor interactions in human proteinopathy. EMBO Rep. 2010;11:479-485.
15. Kimonis VE, Fulchiero E, Vesa J, Watts G. VCP disease associated with myopathy, Paget disease of bone and frontotemporal dementia: review of a unique disorder. Biochim. Biophys. Acta. 2008;1782:744-748.
16. Ju JS, Fuentealba RA, Miller SE, Jackson E, Piwnica -Worms D, Baloh RH, Weihl CC. Valosin-containing protein (VCP) is required for autophagy and is disrupted in VCP disease. J. Cell Biol. 2009;187:875-888.
17. Badadani M, Nalbandian A, Watts GD, Vesa J, Kitazawa M, Su H, Tanaja J, Dec E, Wallace DC, Mukherjee J, et al. VCP associated inclusion body myopathy and paget disease of bone knock-in mouse model exhibits tissue pathology typical of human disease. PloS One 2010;5.
18. Ju JS, Weihl CC. Inclusion body myopathy, Paget's disease of the bone and fronto-temporal dementia: a disorder of autophagy. Hum. Mol. Genet. 2010;19:R38-45.
19. Dai RM, Li CC. Valosin-containing protein is a multi-ubiquitin chain-targeting factor required in ubiquitin-proteasome degradation. Nat. Cell Biol. 2001;3:740-744.
20. Braun RJ, Zischka H. Mechanisms of Cdc48/VCP-mediated cell death: from yeast apoptosis to human disease. Biochim. Biophys. Acta. 2008;1783:1418-1435.
21. McNeill H, Knebel A, Arthur JS, Cuenda A, Cohen P. A novel UBA and UBX domain protein that binds polyubiquitin and VCP and is a substrate for SAPKs. Biochem. J. 2004;384:391-400.
22. Roepman P. The future of diagnostic gene-expression microarrays: bridging the gap between bench and bedside. Bioanalysis 2010;2:249-262.
23. Haslett JN, Kunkel LM. Microarray analysis of normal and dystrophic skeletal muscle. Int. J. Dev. Neurosci. 2002;20:359-365.
24. Haslett JN, Sanoudou D, Kho AT, Bennett RR, Greenberg SA, Kohane IS, Beggs AH, Kunkel LM. Gene expression comparison of biopsies from Duchenne muscular dystrophy (DMD) and normal skeletal muscle. Proc.Natl. Acad. Sci. U. S. A. 2002;99:15000-15005.
25. Greenberg SA, Bradshaw EM, Pinkus JL, Pinkus GS, Burleson T, Due B, Bregoli L, O'Connor KC, Amato AA. Plasma cells in muscle in inclusion body myositis and polymyositis. Neurology. 2005;65:1782-1787.
26. Greenberg SA, Sanoudou D, Haslett JN, Kohane IS, Kunkel LM, Beggs AH, Amato AA. Molecular profiles of inflammatory myopathies. Neurology. 2002;59:1170-1182.
27. Edgar R, Domrachev M, Lash AE. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucl. Acids Res. 2002;30:207-210.
28. Huang da W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protocols. 2009;4:44-57.
29. Huang da W, Sherman BT, Lempicki RA. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucl. Acids Res. 2009;37:1-13.
30. Sit ST, Manser E. Rho GTPases and their role in organizing the actin cytoskeleton. J. Cell Sci.124:679-683.
31. Welf ES, Haugh JM. Signaling pathways that control cell migration: models and analysis. Wiley Interdiscipl. Rev.3:231-240.
32. Avraham R, Yarden Y. Feedback regulation of EGFR signalling: decision making by early and delayed loops. Nat. Rev.12:104-117.
33. Meijer IM, van Leeuwen JE. ERBB2 is a target for USP8-mediated deubiquitination. Cell. Signall.23:458-467.
34. Wong E, Cuervo AM. Autophagy gone awry in neurodegenerative diseases. Nat. Neurosci. 2010;13:805-811.
35. Ohsumi Y. Molecular dissection of autophagy: two ubiquitin-like systems. Nat. Rev. 2001;2:211-216.
36. Mammucari C, Milan G, Romanello V, Masiero E, Rudolf R, Del Piccolo P, Burden SJ, Di Lisi R, Sandri C, Zhao J, et al. FoxO3 controls autophagy in skeletal muscle in vivo. Cell Metab. 2007;6:458-471.
37. Zhao J, Brault JJ, Schild A, Cao P, Sandri M, Schiaffino S, Lecker SH, Goldberg AL. FoxO3 coordinately activates protein degradation by the autophagic/lysosomal and proteasomal pathways in atrophying muscle cells. Cell Metab. 2007;6:472-483.
38. Sengupta A, Molkentin JD, Yutzey KE. FoxO transcription factors promote autophagy in cardiomyocytes. J. Biol. Chem. 2009;284:28319-28331.
39. Yao Z, Seger R. The ERK signaling cascade-views from different subcellular compartments. BioFactors (Oxford, England) 2009;35:407-416.
40. Zehorai E, Yao Z, Plotnikov A, Seger R. The subcellular localization of MEK and ERK-a novel nuclear translocation signal (NTS) paves a way to the nucleus. Mol. Cell. Endocrinol.314:213-220.
41. Daub H, Olsen JV, Bairlein M, Gnad F, Oppermann FS, Körner R, Greff Z, Kéri G, Stemmann O, Mann M. Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle. Mol. Cell. 2008;31:438-448.
42. Yoon S, Seger R. The extracellular signal-regulated kinase: multiple substrates regulate diverse cellular functions. Growth Factors (Chur, Switzerland) 2006;24:21-44.
43. Custer SK, Neumann M, Lu H, Wright AC, Taylor JP. Transgenic mice expressing mutant forms VCP/p97 recapitulate the full spectrum of IBMPFD including degeneration in muscle, brain and bone. Hum. Mol. Genet. 2010;19:1741-1755.
44. Ju JS, Miller SE, Hanson PI, Weihl CC. Impaired protein aggregate handling and clearance underlie the pathogenesis of p97/VCP-associated disease. J. Biol. Chem. 2008;283:30289-30299.
45. Weihl CC, Dalal S, Pestronk A, Hanson PI. Inclusion body myopathy-associated mutations in p97/VCP impair endoplasmic reticulum-associated degradation. Hum. Mol. Genet. 2006;15:189-199.
46. Weihl CC, Miller SE, Hanson PI, Pestronk A. Transgenic expression of inclusion body myopathy associated mutant p97/VCP causes weakness and ubiquitinated protein inclusions in mice. Hum. Mol. Genet. 2007;16:919-928.
47. Hirabayashi M, Inoue K, Tanaka K, Nakadate K, Ohsawa Y, Kamei Y, Popiel AH, Sinohara A, Iwamatsu A, Kimura Y, et al. VCP/p97 in abnormal protein aggregates, cytoplasmic vacuoles, and cell death, phenotypes relevant to neurodegeneration. Cell Death Different. 2001;8:977-984.
48. Mizuno Y, Hori S, Kakizuka A, Okamoto K. Vacuole-creating protein in neurodegenerative diseases in humans. Neurosci. Lett. 2003;343:77-80.
49. Rubinsztein DC. The roles of intracellular protein-degradation pathways in neurodegeneration. Nature. 2006;443:780-786.